![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2008 by The National Academy of Sciences of the USA Medical Sciences The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites *School of Biological Sciences, Nanyang Technological University, Singapore 637551; †Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme and ‡Shoklo Malaria Research Unit, Faculty of Tropical Medicine Research, Mahidol University, Salaya, Nakhon Pathom 73170,Thailand; §Laboratory for Malaria Immunobiology, Singapore Immunology Network, Biopolis, Agency for Science, Technology and Research, Singapore 138632; ¶Department of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel; and ‖Department of Medical Parasitology, New York University Langone Medical Center, New York, NY 10010 **To whom correspondence should be addressed at: School of Biological Science, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551., E-mail: prpreiser/at/ntu.edu.sg Communicated by Louis H. Miller, National Institutes of Health, Rockville, MD, August 18, 2008. Author contributions: Z.B., M.I., F.N., N.P.J.D., N.J.W., and P.R.P. designed research; S.M., M.I., and A.J. performed research; G.H., M.I., B.R., F.N., and J.M.C. contributed new reagents/analytic tools; Z.B., S.M., G.H., B.R., H.G., and P.R.P. analyzed data; and Z.B., B.R., and P.R.P. wrote the paper. Received May 14, 2008. This article has been cited by other articles in PMC.Abstract Plasmodium vivax causes over 100 million clinical infections each year. Primarily because of the lack of a suitable culture system, our understanding of the biology of this parasite lags significantly behind that of the more deadly species P. falciparum. Here, we present the complete transcriptional profile throughout the 48-h intraerythrocytic cycle of three distinct P. vivax isolates. This approach identifies strain specific patterns of expression for subsets of genes predicted to encode proteins associated with virulence and host pathogen interactions. Comparison to P. falciparum revealed significant differences in the expression of genes involved in crucial cellular functions that underpin the biological differences between the two parasite species. These data provide insights into the biology of P. vivax and constitute an important resource for the development of therapeutic approaches. Keywords: comparative genomics, Plasmodium falciparum It is now increasingly recognized that P. vivax infections contribute significantly to the burden of malaria (1, 2). In all endemic areas except for Africa, P. vivax is often the dominant species, and at least 100 million cases are reported annually (2, 3). Although vivax malaria is clinically less likely than P. falciparum to develop into a life threatening disease, it exerts a substantial toll on the individual's health and economic well being. The chronic, long-lasting nature of the infection contributes substantially to morbidity. Chronicity is because of hypnozoites, dormant liver stages from which fresh blood infection or relapses originate up to 2 years after the infectious bite (4). The presence of hypnozoites make infections by P. vivax difficult to cure radically and pose a serious obstacle to the control and eventual eradication of this parasite. The description of the P. falciparum genome (5) and staged erythrocytic transcriptome (6, 7) has provided an invaluable resource for the study of this important species. It would be of fundamental and practical interest to do the same for P. vivax because there are important biological and clinical differences between this species and P. falciparum, whose basis is currently unknown (8). For example, the presence of circulating mature erythrocytic stages of P. vivax would suggest that multigene families and processes implicated in antigenic variation and immune evasion are quite different to P. falciparum, whose mature asexual red cell stages generally sequester. Unlike P. falciparum, P. vivax has a selective preference for infecting reticulocytes (9), strongly suggesting an alternate red cell attachment invasion mechanism. In contrast to the rigid, sticky and knobby P. falciparum infected red cell, P. vivax remodels the host-cell membranes to produce a highly deformable erythrocyte characterized by numerous caveola-vesicle complexes (10–12). Finally, the kinetics of gametocyte production in P. vivax is also different than P. falciparum, with P. vivax gametocytes appearing much earlier and being relatively short lived (8). Aside from these notable interspecies differences, there are a number of important phenotypic differences within P. vivax relating to relapse periodicity and chloroquine sensitivity, which the mechanisms behind these differences are still unknown. Investigations into the biology of P. vivax have been restricted by the lack of a continuous cultivation system. With advances of sequencing technology, the P. vivax genome is now available (13), allowing the construction of a representative microarray. This significant advance, coupled with the ability to mature ex vivo isolates, has opened the way to obtain a high-quality transcriptome of the blood stages. This study aimed to provide a stage-specific transcriptome of the intraerythrocytic developmental cycle (IDC) of P. vivax which can be compared with P. falciparum (6). Although the IDC represents only a relatively small portion of the Plasmodium life cycle, close to two thirds of Plasmodium genes are expressed and transcriptionally regulated during this 48-h development (6, 7). Thus, characterizing the P. vivax IDC transcriptome will provide broad insights into the P. vivax biology and gene functionalities of this parasite. In addition, three separate clinical isolates of P. vivax were used to provide some indication into the magnitude of intraspecies IDC transcriptome variation [see supporting information (SI) Dataset S1, Dataset S2, and Dataset S3]. Results and Discussion Transcriptional Regulation of P. vivax Genes During the Erythrocytic Stage. To study the IDC transcriptome of P. vivax, we collected three clinical isolates from acute vivax malaria patients before treatment on the Northwestern border of Thailand (Shoklo Malaria Research Unit, Mahidol University, Mae Sot, Thailand). These synchronous, monoclonal, erythrocytic isolates were cultured ex vivo from the early ring stage to the schizont stage (see Table S1) (12, 14). Transcriptional analysis using a genome-wide long oligonucleotide microarray designed by the recently established algorithm OligoRankPick (15) showed that during the P. vivax IDC, each gene is activated at a particular developmental stage analogous to P. falciparum (Fig. 1
Comparison of the P. vivax and P. falciparum IDC Transcriptomes. Expression of the majority of P. vivax nonsyntenic genes at the schizont-ring transition. Comparison of the P. vivax and the published P. falciparum IDC transcriptome shows a striking difference in the distribution of IDC-specific gene transcription between P. vivax-P. falciparum syntenic and nonsyntenic genes. Whereas the peaks of expression of syntenic genes are distributed evenly throughout the IDC, with slight bias toward the trophozoite-schizont transition, the global distribution of mRNA abundance of the nonsyntenic genes exhibits a strong preference toward the extremes of the IDC; the schizont-ring stage transition (Fig. 1 Transcriptional shift of several conserved functions in the P. vivax IDC. Pearson correlation comparisons between the P. vivax and P. falciparum IDC transcriptomes (Fig. S4) revealed that although the majority of P. vivax genes exhibit identical transcriptional regulation, considerable differences exist for a small portion of the P. vivax genome (Fig. 2
To gain further insights into the impact of the alterations of transcriptional regulation on P. vivax physiology, we analyzed gene expression correlations within the functionally related gene groups that were classified by the Malaria Parasite Metabolic Pathway database (24). All functional groups exhibited high levels of correlations between the IDC transcriptional profiles and median values ranging from 0.6516 (DNA replication) to 0.9033 (translation initiation) (Fig. S5). These data indicate that the IDC timing of the majority of biological functions is conserved between P. vivax and P. falciparum. However, essentially every functionally related gene group contains a small fraction of genes whose transcriptional timing is shifted between the IDCs of P. falciparum and P. vivax. More studies will be required to determine whether these genes evolved into different biological roles or whether they represent an extended functionality of the conserved pathway. For several functional groups, we observed transcriptional shifts for a high proportion of their genes which suggest significant changes in their timing during the IDC (Table S2). Two H+ pumping mechanisms have been implicated in maintaining the pH within the food vacuole (25), and although there is no difference in the expression profile of the H+-pyrophoshatase, there is a dramatic shift of expression of three major subunits of the vacuolar H+-ATPase suggesting a more gradual acidification of the food vacuole organelle throughout the P. vivax IDC compared with P. falciparum (25). The food vacuole in malaria parasites is the site of hemoglobin degradation, and thus hemoglobin degradation in P. vivax may proceed at a more gradual rate (Table S2). This is corroborated by a similar transcriptional shift of the major hemoglobinases plasmepsinIV and falcipain2 and 3, and an amino acid transporter that is implicated in the removal of unused amino acids released during hemoglobin degradation (26). In P. falciparum, both copies of falcipain2 show strong expression in the ring/trophozoite stage with falcipain3 being transcribed only very weakly throughout the whole-time course (6). In contrast, in P. vivax, both falcipain3 and the nonsyntenic copy of falcipain2 show strong expression in the early schizonts stage, whereas the syntenic copy of falcipain2 shows evenly distributed transcription throughout the time course. Interestingly, in P. falciparum, plasmepsinIV has been expanded by three additional paralogs (plasmepsin I, II, HAP), all of which show peak expression in the early ring or trophozoite stage compared with the peak of expression in early schizonts for the P. vivax gene. This further supports potential differences in the hemoglobin degradation process between these two species. These results may also, in part, explain the recently described differences in chloroquine sensitivity of P. vivax trophozoites (27). Another marked difference involves the exp1 and exp2 genes and the etramp family, which are linked with the development of the parasitophorous vacuole (PV) that surrounds the intracellular parasite and is formed immediately after invasion in P. falciparum (28). In P. vivax, both Exp genes and four etramp genes are expressed in schizonts. Variation in the development of the PV, because of the delay of exp and etramp gene expression, might contribute to differences in erythrocyte modifications and lead to the observed differences in rigidity and cytoadherence between P. vivax and P. falciparum infected erythrocytes (12). Consistent with the differences in rigidity and cytoadherance properties between the two Plasmodium species is the observation that P. vivax lacks the genes of the ring-infected erythrocyte surface antigen (resa) family whose function is linked with the increased rigidity of P. falciparum infected erythrocytes (29). RESA proteins were found to be transported to the erythrocytic cytoskeleton via distinct compartments of the PV immediately after invasion (30). Of the 65 P. falciparum predicted protein kinases (31), 49 syntenic orthologs were found to be transcriptionally regulated through the P. vivax IDC. Expression of 11 of these, however, is considerably delayed in P. vivax. Nine of these belong to the CMGC, NIMA, or CamK classes that are linked to developmental processes and/or regulation of cell proliferation (Table S2). One of these is a well characterized serine/threonine protein kinase PfNek1 (32) whose expression is shifted from early to late schizonts. The Nek1 kinases were found to be involved in the onset of mitosis in other organisms (33). The transcriptional delays of PfNek1 and other protein kinases might signal a delayed onset and progression of P. vivax schizogony compared with P. falciparum. This is consistent with the observed delay in expression of a number of DNA replication factors during the P. vivax IDC (Table S2). Proteins containing the AP2-integrase, DNA-binding domain have been recently implicated in the global regulation of the Plasmodium life cycle (34, 35). All 22 P. falciparum AP2 proteins have syntenic homologues in P. vivax, of which 19 exhibit identical IDC expression profiles between these two species; one homologue (Pv118015) is shifted from the trophozoite stage in P. falciparum to the late schizont stage in P. vivax, and two homologues (Pv086035 and Pv094580) were below the detection threshold of the P. vivax microarray. These data indicate a conserved role of the AP2 proteins in the regulation of the Plasmodium life cycle, but more analyses will be required to determine whether Pv118015, the outlying ortholog, contributes significantly to the transcriptional diversion between the two plasmodium species. Transcriptional changes between P. vivax and P. falciparum are driven from regulatory elements of individual genes. The distribution of transcriptional regulation along Plasmodium chromosomes shows no apparent association with any particular chromosomal region or domain, and differentially expressed genes are evenly scattered along the chromosomes (Fig. 3
Variation of Transcription in Different P. vivax Isolates. Although P. vivax is generally associated with benign pathology, a wide spectrum of clinical manifestations, including severe and even lethal infections, was reported from many endemic regions including Papua New Guinea, Indonesian Papua, and Sri Lanka (2, 36). This indicates a considerable variability in the host–parasite interactions, virulence, and the growth and transmission rate. Although many recent large-scale genotyping efforts brought some insights in to the P. vivax genetic diversity (37), including gene amplifications (38), little is known about how this translates to intraspecies variability of P. vivax gene expression. Our pairwise comparisons between the three IDC transcriptomes revealed that the timing of gene expression is completely conserved in each isolate with median Pearson correlation ranging from 0.785 ± 0.223 to 0.862 ± 0.207 (Fig. S1). However, significant differences in the total mRNA levels between P. vivax isolates were detected for 249 genes (P value < 0.05) (Fig. 4
Fernandez-Becerra et al.(39) has shown that in natural infections, P. vivax isolates express “large and mostly nonoverlapping” vir gene repertoires. This phenomenon was attributed mainly to the extensive polymorphisms detected in the vir gene family. To assess the level of polymorphisms among the three isolates, we carried out comparative genomic hybridization in a pairwise manner. Of the 262 total, 177 vir-specific oligonucleotide elements present on the P. vivax microarray exhibited equal hybridization signal (P value < 0.05) between any given isolate pair. Of these 177, 153 showed significant expression in all three isolates. Interestingly, 89 (of the 153) vir-genes exhibit identical expression levels whereas 26, 16, and 19 show a significantly increased mRNA abundance in one of the three isolates, respectively (Fig. 4 Conclusions There is mounting evidence that the transcriptional cascade of the P. falciparum IDC is highly conserved between different strains obtained from in vitro and in vivo growth (7, 45, 46). Moreover, growth perturbations of P. falciparum parasites induce only miniscule changes in the global transcriptional pattern (47). In P. vivax, we also fail to detect any differences in the timing of gene expression during the IDC between different isolates. These findings are consistent with predictions that the timing of gene expression during the IDC of Plasmodium species does not fluctuate between different strains or isolates (46). Thus, it is reasonable to speculate that many (if not all) of the observed interspecies variations represent conserved transcriptional differences that reflect evolution of the individual Plasmodium species. Similar to P. falciparum, the intraerythrocytic development of P. vivax is characterized by extensive transcriptional regulation in which each biological function is timed to a specific section of the IDC. Although most of the P. vivax genes exhibit an identical expression profile across the IDC compared with their P. falciparum syntenic orthologs, there are partial shifts as well as dramatic alterations in the mRNA abundance profiles for 22% and 11% genes, respectively. In several cases, these changes represent substantial alteration of the timing for an entire biological function including hemoglobin degradation, host parasite interaction, protein export to the host-cell cytoplasm, and DNA replication. In contrast to the conserved portion of the P. vivax genome, the nonsyntenic P. vivax genes are activated predominantly at the schizont/ring interphase which suggests that the species differences derive mainly from events occurring at red cell invasion and early intraerythrocytic development. Moreover, expression of the majority of vir and pvtrag gene families throughout the IDC indicate major differences in antigenic presentation between P. falciparum and P. vivax. The even distribution of the differentially expressed genes along the P. vivax-P. falciparum chromosomal synteny blocks suggests that the diversion of transcriptional control between these two species occurred at the regulatory elements of individual genes. The intraisolate diversity of gene expression indicates an extensive capacity of P. vivax to adapt to its host and modify its virulence. This fundamental, biological information about P. vivax should facilitate the development of innovative control measures against this remarkably resilient parasite. Materials and Methods Sample Collection and RNA Isolation. Adult patients from Northwestern Thailand (Shoklo Malaria Research Unit, Mahidol University, Thailand) with symptomatic vivax malaria gave informed consent to donate 10 ml of blood. The P. vivax infected blood samples were collected from three preselected patients before receiving standard chloroquine treatment. For more details, see SI Text. Target DNA Preparations and Microarray Analysis. The microarray contained 5,727 60-mer oligonucleotides that represented a total of 5,335 predicted genes in the P. vivax genome by at least one unique probe. From these, 5,063 are represented by a single oligonucleotide, whereas 272 genes (typically long ORFs) are represented by two or more oligonucleotide elements. The P. vivax microarray oligonucleotide set was designed by OligoRankPick (15). Sequences of all oligonucleotides and further information are available online at http://zblab.sbs.ntu.edu.sg/vivax/index.html. The P. virax long-oligo array is also available through the Pathogen Functional Genomics Resource Center (http://pfgrc.jcvi.org). Supporting Information
Acknowledgments. This work was supported by Biomedical Research Council Singapore Grants BMRC 04/1/22/19/364 and BMRC 05/1/22/19/398 and National Medical Research Council Singapore Grant NMRC/CPG/016/2005. Footnotes The authors declare no conflict of interest. This article contains supporting information online at www.pnas.org/cgi/content/full/0807404105/DCSupplemental. References 1. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64:97–106. [PubMed] 2. Price RN, et al. Vivax malaria: Neglected and not benign. Am J Trop Med Hyg. 2007;77:79–87. [PubMed] 3. Hay SI, et al. The global distribution and population at risk of malaria: Past, present, and future. Lancet Infect Dis. 2004;4:327–336. [PubMed] 4. Krotoski WA, et al. Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. Am J Trop Med Hyg. 1986;35:263–274. [PubMed] 5. Gardner MJ, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002;419:498–511. [PubMed] 6. Bozdech Z, et al. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 2003;1:E5. [PubMed] 7. Le Roch KG, et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science. 2003;301:1503–1508. [PubMed] 8. Grannham PCC. Malaria Parasites and Haemosporidia. Oxford: Blackwell Scientific Publications; 1966. 9. Mons B. Preferential invasion of malarial merozoites into young red blood cells. Blood Cells. 1990;16:299–312. [PubMed] 10. Aikawa M. Parasitological review. Plasmodium: The fine structure of malarial parasites. Exp Parasitol. 1971;30:284–320. [PubMed] 11. Aikawa M, Miller LH, Rabbege J. Caveola–vesicle complexes in the plasmalemma of erythrocytes infected by Plasmodium vivax and P cynomolgi. Unique structures related to Schuffner's dots. Am J Pathol. 1975;79:285–300. [PubMed] 12. Suwanarusk R, et al. The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. J Infect Dis. 2004;189:190–194. [PubMed] 13. Carlton J, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008 in press. 14. Russell BM, et al. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother. 2003;47:170–173. [PubMed] 15. Hu G, et al. Selection of long oligonucleotides for gene expression microarrays using weighted rank-sum strategy. BMC Bioinformatics. 2007;8:350–362. [PubMed] 16. del Portillo HA, et al. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature. 2001;410:839–842. [PubMed] 17. Jalah R, et al. Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Mol Biochem Parasitol. 2005;142:158–169. [PubMed] 18. Duraisingh MT, et al. Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum. Cell. 2005;121:13–24. [PubMed] 19. Freitas-Junior LH, et al. Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites. Cell. 2005;121:25–36. [PubMed] 20. Tham WH, Payne PD, Brown GV, Rogerson SJ. Identification of basic transcriptional elements required for rif gene transcription. Int J Parasitol. 2007;37:605–615. [PubMed] 21. Galinski MR, Medina CC, Ingravallo P, Barnwell JW. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell. 1992;69:1213–1226. [PubMed] 22. Drew DR, Sanders PR, Crabb BS. Plasmodium falciparum merozoite surface protein 8 is a ring-stage membrane protein that localizes to the parasitophorous vacuole of infected erythrocytes. Infect Immun. 2005;73:3912–3922. [PubMed] 23. Rug M, et al. The role of KAHRP domains in knob formation and cytoadherence of P falciparum-infected human erythrocytes. Blood. 2006;108:370–378. [PubMed] 24. Ginsburg H. Progress in in silico functional genomics: The malaria Metabolic Pathways database. Trends Parasitol. 2006;22:238–240. [PubMed] 25. Saliba KJ, et al. Acidification of the malaria parasite's digestive vacuole by a H+-ATPase and a H+-pyrophosphatase. J Biol Chem. 2003;278:5605–5612. [PubMed] 26. Martin RE, et al. The “permeome” of the malaria parasite: An overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol. 2005;6:R26. [PubMed] 27. Sharrock WW, et al. Plasmodium vivax trophozoites insensitive to chloroquine. Malar J. 2008;7:94–100. [PubMed] 28. Spielmann T, et al. Organization of ETRAMPs and EXP-1 at the parasite-host cell interface of malaria parasites. Mol Microbiol. 2006;59:779–794. [PubMed] 29. Mills JP, et al. Effect of plasmodial RESA protein on deformability of human red blood cells harboring Plasmodium falciparum. Proc Natl Acad Sci USA. 2007;104:9213–9217. [PubMed] 30. Culvenor JG, Day KP, Anders RF. Plasmodium falciparum ring-infected erythrocyte surface antigen is released from merozoite dense granules after erythrocyte invasion. Infect Immun. 1991;59:1183–1187. [PubMed] 31. Ward P, Equinet L, Packer J, Doerig C. Protein kinases of the human malaria parasite Plasmodium falciparum: The kinome of a divergent eukaryote. BMC Genomics. 2004;5:79–97. [PubMed] 32. Dorin D, et al. PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum. Mol Microbiol. 2005;55:184–196. [PubMed] 33. Osmani SA, Pu RT, Morris NR. Mitotic induction and maintenance by overexpression of a G2-specific gene that encodes a potential protein kinase. Cell. 1988;53:237–244. [PubMed] 34. Balaji S, Babu MM, Iyer LM, Aravind L. Discovery of the principal specific transcription factors of Apicomplexa and their implication for the evolution of the AP2-integrase DNA binding domains. Nucleic Acids Res. 2005;33:3994–4006. [PubMed] 35. De Silva EK, et al. Specific DNA-binding by apicomplexan AP2 transcription factors. Proc Natl Acad Sci USA. 2008;105:8393–8398. [PubMed] 36. Tjitra E, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Med. 2008;5:e128. [PubMed] 37. Karunaweera ND, et al. Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. Gene. 2008;410:105–112. [PubMed] 38. Suwanarusk R, et al. Chloroquine resistant Plasmodium vivax: In vitro characterisation and association with molecular polymorphisms. PLoS ONE. 2007;2:e1089. [PubMed] 39. Fernandez-Becerra C, et al. Variant proteins of Plasmodium vivax are not clonally expressed in natural infections. Mol Microbiol. 2005;58:648–658. [PubMed] 40. Sargeant TJ, et al. Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol. 2006;7:R12. [PubMed] 41. Cortes A, et al. Epigenetic silencing of Plasmodium falciparum genes linked to erythrocyte invasion. PLoS Pathog. 2007;3:e107. [PubMed] 42. Iyer JK, Amaladoss A, Genesan S, Preiser PR. Variable expression of the 235-kDa rhoptry protein of Plasmodium yoelii mediate host cell adaptation and immune evasion. Mol Microbiol. 2007;65:333–346. [PubMed] 43. Nery S, et al. Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients. Mol Biochem Parasitol. 2006;149:208–215. [PubMed] 44. Gaur D, Mayer DC, Miller LH. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol. 2004;34:1413–1429. [PubMed] 45. Daily JP, et al. Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature. 2007;450:1091–1095. [PubMed] 46. Llinas M, et al. Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains. Nucleic Acids Res. 2006;34:1166–1173. [PubMed] 47. Gunasekera AM, et al. Plasmodium falciparum: Genome wide perturbations in transcript profiles among mixed stage cultures after chloroquine treatment. Exp Parasitol. 2007;117:87–92. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Am J Trop Med Hyg. 2001 Jan-Feb; 64(1-2 Suppl):97-106.
[Am J Trop Med Hyg. 2001]Am J Trop Med Hyg. 2007 Dec; 77(6 Suppl):79-87.
[Am J Trop Med Hyg. 2007]Lancet Infect Dis. 2004 Jun; 4(6):327-36.
[Lancet Infect Dis. 2004]Am J Trop Med Hyg. 1986 Mar; 35(2):263-74.
[Am J Trop Med Hyg. 1986]Nature. 2002 Oct 3; 419(6906):498-511.
[Nature. 2002]PLoS Biol. 2003 Oct; 1(1):E5.
[PLoS Biol. 2003]Science. 2003 Sep 12; 301(5639):1503-8.
[Science. 2003]Blood Cells. 1990; 16(2-3):299-312.
[Blood Cells. 1990]Exp Parasitol. 1971 Oct; 30(2):284-320.
[Exp Parasitol. 1971]PLoS Biol. 2003 Oct; 1(1):E5.
[PLoS Biol. 2003]Science. 2003 Sep 12; 301(5639):1503-8.
[Science. 2003]J Infect Dis. 2004 Jan 15; 189(2):190-4.
[J Infect Dis. 2004]Antimicrob Agents Chemother. 2003 Jan; 47(1):170-3.
[Antimicrob Agents Chemother. 2003]BMC Bioinformatics. 2007 Sep 19; 8():350.
[BMC Bioinformatics. 2007]PLoS Biol. 2003 Oct; 1(1):E5.
[PLoS Biol. 2003]PLoS Biol. 2003 Oct; 1(1):E5.
[PLoS Biol. 2003]Nature. 2001 Apr 12; 410(6830):839-42.
[Nature. 2001]Mol Biochem Parasitol. 2005 Aug; 142(2):158-69.
[Mol Biochem Parasitol. 2005]Cell. 2005 Apr 8; 121(1):13-24.
[Cell. 2005]Cell. 2005 Apr 8; 121(1):25-36.
[Cell. 2005]Int J Parasitol. 2007 May; 37(6):605-15.
[Int J Parasitol. 2007]Infect Immun. 2005 Jul; 73(7):3912-22.
[Infect Immun. 2005]Blood. 2006 Jul 1; 108(1):370-8.
[Blood. 2006]Trends Parasitol. 2006 Jun; 22(6):238-40.
[Trends Parasitol. 2006]J Biol Chem. 2003 Feb 21; 278(8):5605-12.
[J Biol Chem. 2003]Genome Biol. 2005; 6(3):R26.
[Genome Biol. 2005]PLoS Biol. 2003 Oct; 1(1):E5.
[PLoS Biol. 2003]Malar J. 2008 May 27; 7():94.
[Malar J. 2008]Mol Microbiol. 2006 Feb; 59(3):779-94.
[Mol Microbiol. 2006]J Infect Dis. 2004 Jan 15; 189(2):190-4.
[J Infect Dis. 2004]Proc Natl Acad Sci U S A. 2007 May 29; 104(22):9213-7.
[Proc Natl Acad Sci U S A. 2007]Infect Immun. 1991 Mar; 59(3):1183-7.
[Infect Immun. 1991]BMC Genomics. 2004 Oct 12; 5(1):79.
[BMC Genomics. 2004]Mol Microbiol. 2005 Jan; 55(1):184-96.
[Mol Microbiol. 2005]Cell. 1988 Apr 22; 53(2):237-44.
[Cell. 1988]Nucleic Acids Res. 2005; 33(13):3994-4006.
[Nucleic Acids Res. 2005]Proc Natl Acad Sci U S A. 2008 Jun 17; 105(24):8393-8.
[Proc Natl Acad Sci U S A. 2008]PLoS Biol. 2003 Oct; 1(1):E5.
[PLoS Biol. 2003]Am J Trop Med Hyg. 2007 Dec; 77(6 Suppl):79-87.
[Am J Trop Med Hyg. 2007]PLoS Med. 2008 Jun 17; 5(6):e128.
[PLoS Med. 2008]Gene. 2008 Feb 29; 410(1):105-12.
[Gene. 2008]PLoS One. 2007 Oct 31; 2(10):e1089.
[PLoS One. 2007]Mol Microbiol. 2005 Nov; 58(3):648-58.
[Mol Microbiol. 2005]Mol Biochem Parasitol. 2005 Aug; 142(2):158-69.
[Mol Biochem Parasitol. 2005]Genome Biol. 2006; 7(2):R12.
[Genome Biol. 2006]PLoS Pathog. 2007 Aug 3; 3(8):e107.
[PLoS Pathog. 2007]Mol Microbiol. 2007 Jul; 65(2):333-46.
[Mol Microbiol. 2007]Science. 2003 Sep 12; 301(5639):1503-8.
[Science. 2003]Nature. 2007 Dec 13; 450(7172):1091-5.
[Nature. 2007]Nucleic Acids Res. 2006; 34(4):1166-73.
[Nucleic Acids Res. 2006]Exp Parasitol. 2007 Sep; 117(1):87-92.
[Exp Parasitol. 2007]BMC Bioinformatics. 2007 Sep 19; 8():350.
[BMC Bioinformatics. 2007]PLoS Biol. 2003 Oct; 1(1):E5.
[PLoS Biol. 2003]